President Donald Trump is weighing whether to shift marijuana to a less severe drug classification group after receiving millions from cannabis companies.

Trump confirmed that he was considering the possibility during a recent fundraising event at his New Jersey golf club, where a seat cost $1 million, insiders told The Wall Street Journal.

One of the fundraiser’s attendees was Kim Rivers, CEO of the cannabis company Trulieve, which is one of the firms that has donated large sums to Trump, according to insiders.

The Department of Health and Human Services currently groups marijuana in its highest classification group. Other Schedule 1 drugs include heroin, LSD, and ecstasy.

While marijuana remains a federally controlled substance, 24 states have legalized the drug for recreational use

See Full Page